Extramedullary disease in multiple myeloma
Clinical trials for Extramedullary disease in multiple myeloma explained in plain language.
Never miss a new study
Get alerted when new Extramedullary disease in multiple myeloma trials appear
Sign up with your email to follow new studies for Extramedullary disease in multiple myeloma, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Radiation boosts cancer drug in Tough-to-Treat myeloma
Disease control Recruiting nowThis study tests whether adding low-dose radiation to the drug elranatamab can better kill cancer cells in people with multiple myeloma that has come back or not responded to treatment and has spread outside the bone. About 34 adults will receive the combination. The goal is to s…
Matched conditions: EXTRAMEDULLARY DISEASE IN MULTIPLE MYELOMA
Phase 2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
New drug cocktail targets myeloma tumors outside the bone marrow
Disease control Recruiting nowThis phase II trial tests a combination of three drugs—mezigdomide, carfilzomib, and dexamethasone—in 28 patients with multiple myeloma that has returned or not responded to treatment and has spread to soft tissues or organs. The goal is to see if this combo can shrink tumors or …
Matched conditions: EXTRAMEDULLARY DISEASE IN MULTIPLE MYELOMA
Phase 2 • Sponsor: Roswell Park Cancer Institute • Aim: Disease control
Last updated Aug 20, 2026 00:00 UTC